Junshik Hong

Seoul National University — South Korea

Medicine · Health Sciences

30h-index2.9kcitations294works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(73), Lymphoma Diagnosis and Treatment(54), Myeloproliferative Neoplasms: Diagnosis and Treatment(27), Multiple Myeloma Research and Treatments(25), Hematopoietic Stem Cell Transplantation(24)

Publications294 total

Clinical Outcomes of Low‐Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir Prophylaxis
Journal of Medical Virology·2025
Brentuximab vedotin combined with cisplatin, cytarabine, and dexamethasone treatment in transplant-eligible Korean patients with relapsed or refractory Hodgkin’s lymphoma
Blood Research·2025· 1 citedOpen Access
A comparative study of hematologic response to ropeginterferon alfa-2b in hydroxyurea-resistant or intolerant polycythemia vera: a real-world data-based analysis
Blood Research·2025Open Access
Old mismatched donors are associated with inferior outcomes after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndrome, but not in Acute Myeloid Leukemia
Blood·2025Open Access
Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes
Blood Research·2025Open Access
Azacitidine followed by R-GDP in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: preliminary results from a multicenter, phase II study
Therapeutic Advances in Hematology·2025· 1 citedOpen Access
Self-modulating therapeutic platform using engineered miRNA-responsive oligonucleotides
Nano Convergence·2025· 1 citedOpen Access
The role of ASXL1, SRSF2, and EZH2 mutations in chromatin dysregulation of myelodysplastic neoplasia and acute myeloid leukemia
Leukemia·2025· 5 citedOpen Access
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study
Annals of Hematology·2025· 2 citedOpen Access
Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndrome
Leukemia Research·2025· 3 cited
319 | ANBALCABTAGENE AUTOLEUCEL (PD‐1 AND TIGIT KNOCKDOWN CD19 CAR‐T) FOR RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA (CRC01‐01)
Hematological Oncology·2025Open Access
Prognostic Landscape of <i>TP53</i> Mutations in Hematologic Malignancies
Cancer Research and Treatment·2025· 1 citedOpen Access
Abstract 5002: Multi-omics insights into the role of clonal hematopoiesis in multiple myeloma
Cancer Research·2025
Abstract 891: Therapeutic role of NK cells in treatment of myeloid malignancies using hypomethylating agents
Cancer Research·2025
Concurrence of prothrombin nonneutralizing antibody and factor XI neutralizing inhibitor in lupus anticoagulant positive patient
Blood Coagulation & Fibrinolysis·2025
Prolactin level changes according to atypical antipsychotics use
European Psychiatry·2025Open Access
Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma
Annals of Hematology·2025· 3 citedOpen Access
Selinexor plus ruxolitinib in JAK inhibitor treatment-naïve myelofibrosis: SENTRY Phase 3 study design
Future Oncology·2025· 3 citedOpen Access
Increased local DNA methylation disorder in AMLs with DNMT3A-destabilizing variants and its clinical implication
Nature Communications·2025· 9 citedOpen Access
Mesenteric Vein Thrombosis
Clinical & Experimental Thrombosis and Hemostasis·2024· 2 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Jinny Park(22), Dong Bok Shin(21), Eun Kyung Cho(20), Sun Jin Sym(16), Jae Hoon Lee(13), Dong‐Yeop Shin(12), Hee Kyung Ahn(11), Jae Hoon Lee(9), Young Saing Kim(8), Youngil Koh(8), Jeong Yeal Ahn(7), Se Hoon Park(7), Soo‐Mee Bang(7), Sung‐Soo Yoon(7), Inho Kim(7), Ho‐Young Yhim(6), Jae-Ik Lee(4), Inkeun Park(4), Sung Hwa Bae(4), Ja Min Byun(4)